Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages
about
Angiopoietin-like 4 regulates epidermal differentiation.Implication of hepatokines in metabolic disorders and cardiovascular diseasesAngiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubesFatty acid-inducible ANGPTL4 governs lipid metabolic response to exerciseAngiopoietin-like 4: a decade of researchAngiopoietin-like protein 4: health effects, modulating agents and structure-function relationshipsANGPTL4 is produced by entero-endocrine cells in the human intestinal tractShort-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γMechanisms of inflammatory responses in obese adipose tissue.Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue.The full capacity of AICAR to reduce obesity-induced inflammation and insulin resistance requires myeloid SIRT1Impaired transcriptional response of the murine heart to cigarette smoke in the setting of high fat diet and obesity.Genetics of coronary artery disease: discovery, biology and clinical translation.Inflammation increases plasma angiopoietin-like protein 4 in patients with the metabolic syndrome and type 2 diabetes.Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity.Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activitySerum angiopoietin-like 4 protein levels and expression in adipose tissue are inversely correlated with obesity in monozygotic twins.Lymphatic vascular morphogenesis in development, physiology, and diseasePhenotypic flexibility as key factor in the human nutrition and health relationship.Lipoprotein lipase as a candidate target for cancer prevention/therapyGut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colonLactobacillus rhamnosus CNCMI-4317 Modulates Fiaf/Angptl4 in Intestinal Epithelial Cells and Circulating Level in Mice.Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity.The ATP-P2X7 signaling axis is dispensable for obesity-associated inflammasome activation in adipose tissue.Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice.Natural killer T cells in adipose tissue prevent insulin resistanceAngptl4 links α-cell proliferation following glucagon receptor inhibition with adipose tissue triglyceride metabolism.Adipose-specific lipoprotein lipase deficiency more profoundly affects brown than white fat biology.Myeloid Deletion of α1AMPK Exacerbates Atherosclerosis in LDL Receptor Knockout (LDLRKO) Mice.The Arg59Trp variant in ANGPTL8 (betatrophin) is associated with total and HDL-cholesterol in American Indians and Mexican Americans and differentially affects cleavage of ANGPTL3.Inactivating Variants in ANGPTL4 and Risk of Coronary Artery DiseaseANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression.Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets.Adipose tissue angiogenesis: impact on obesity and type-2 diabetes.Association of postalimentary lipemia with atherosclerotic manifestations.Potential mediators linking gut bacteria to metabolic health: a critical view.Lymphatic transport of high-density lipoproteins and chylomicrons.Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation.Stressed out about obesity: IRE1α-XBP1 in metabolic disorders.Role of the gut in visceral fat inflammation and metabolic disorders.
P2860
Q21135146-946A66E8-BB7F-4377-8E48-633798566043Q26751147-513E0DA5-B5C7-43C8-B65D-C0A7E03778FFQ27316586-B850228F-371F-4456-946F-11548911F502Q28235151-2EB4175D-1B60-4749-92A7-C7131AA46E29Q28263089-0E220AF6-8203-46AF-A7DE-EF398F618C8AQ28263229-F501EEB9-DF23-4ACA-96EF-390707927CDDQ28300566-EFDFF1E5-3FC3-4D34-A035-6267CC86B41DQ30538765-4B5AE96D-E6BD-4AF2-91D3-592F8C0D1902Q33699810-E13CD0B5-52B2-4B4B-9C26-284EC429179DQ34486733-9E412E69-D2CD-466B-A2C0-0FDC43F691B4Q34489201-7FB83943-B4FD-4CC1-894E-B60B5FA1695DQ34523438-8C3D784D-C854-46C4-BC07-14FAC04D3343Q34553141-06C3B514-02DB-49FC-BBBD-B7253C6BF23EQ34692490-A93CDD8C-D981-4368-956A-EE629D7D6BFAQ34963041-7A274836-0308-4860-A960-03DE5C4F958EQ35040568-8F710AF9-7678-45FF-9D33-0684611C2D99Q35107317-9696B2DD-4965-4CF9-8CDC-5A4044D70794Q35196040-75C2DA74-A2D5-40BA-B283-6FA0BF1B14E4Q35222025-9DDCB980-DBDE-41E9-827C-9245424899D6Q35418859-2B6029B9-6736-4F4E-A330-569DCDD3106DQ35718030-D0BC6D02-943B-43CA-9922-73131AD0180EQ35800407-BD7CBED3-DD78-425A-8A82-6088B0CB506FQ35922180-56CDEB54-4CFB-46DE-B80E-9B981D580113Q35976791-A0B3CD11-F70A-4676-A5CA-7FC8B0E5FC50Q35982680-D0E43DD9-13C7-4B32-B890-A7E0A7207535Q36190718-157C6A2E-DAA5-4F84-9A10-36F10A5BF8C4Q36394289-2527989E-27ED-4F42-9E0A-CB7A0EEC0970Q36850211-EB1A6B06-12FB-4DE9-9F69-5A2C05063862Q36930766-FDC8B30A-2255-4F72-B973-2447FF54CB85Q36936141-661579A7-7A30-45A9-8EED-ED958AA4B9C2Q36988623-A9D45DA3-043C-47DC-8D6A-BDA168B5A93FQ37153606-2282FF4C-E0A8-471D-9441-7B413F0509CBQ37333795-7EC59EDB-2584-49C5-8C39-E446B9BC60A8Q37352210-6BB61F3D-DB99-469B-8C62-ED2B59984845Q37370790-4D106287-9798-4396-9C09-1AF98507981FQ37583957-CB820AED-40B9-45B0-B95F-4BA62C42023AQ37602219-060DA960-762F-46EC-AA06-2FA4CBF0F9EAQ37612556-3BDFBC16-346E-48A4-8B2D-F1D60C008F7DQ37894253-97939D69-B3D3-4DD3-8D5D-D8B5866ADB89Q37924590-F5ACA24E-E387-429E-8C25-AFB07D87EEA5
P2860
Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Angptl4 protects against sever ...... enteric lymph node macrophages
@ast
Angptl4 protects against sever ...... enteric lymph node macrophages
@en
Angptl4 protects against sever ...... enteric lymph node macrophages
@nl
type
label
Angptl4 protects against sever ...... enteric lymph node macrophages
@ast
Angptl4 protects against sever ...... enteric lymph node macrophages
@en
Angptl4 protects against sever ...... enteric lymph node macrophages
@nl
prefLabel
Angptl4 protects against sever ...... enteric lymph node macrophages
@ast
Angptl4 protects against sever ...... enteric lymph node macrophages
@en
Angptl4 protects against sever ...... enteric lymph node macrophages
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Angptl4 protects against sever ...... enteric lymph node macrophages
@en
P2093
Anastasia Georgiadi
Anja Köster
Frits Mattijssen
Jouke T Tamsma
Nicole J de Wit
Roelof van der Meer
P2860
P304
P3181
P356
10.1016/J.CMET.2010.11.002
P407
P577
2010-12-01T00:00:00Z